Jonathan Farhi
Angers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.
Journal: American journal of hematology
Published: October 15, 2024
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.
Journal: Kidney international reports
Published: June 30, 2023
R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory study.
Journal: European journal of haematology
Published: December 29, 2019
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 25, 2019
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine.
Journal: Cancer medicine
Published: October 20, 2018
Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis
Journal: Annales de biologie clinique
Published: August 07, 2018
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
Journal: Annals of hematology
Published: May 27, 2018
Significant impact of immunosuppression on the incidence of secondary malignancies following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with indolent B-cell neoplasms.
Journal: Leukemia & lymphoma
Published: March 22, 2018
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine.
Journal: Experimental hematology
Published: March 08, 2018
Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.
Journal: Haematologica
Published: December 23, 2017
Last Updated: 09/26/2026